Artificial Intelligent Multi-Modal Point-of-Care System for Predicting Response of Transarterial Chemoembolization in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) ranks the second most lethal tumor globally and is the fourth leading cause of cancer-related death worldwide. Unfortunately, HCC is commonly at intermediate tumor stage or advanced tumor stage, in which only some palliative treatment can be used to offer a limited ove...
Main Authors: | Zhongqi Sun, Zhongxing Shi, Yanjie Xin, Sheng Zhao, Hao Jiang, Dandan Wang, Linhan Zhang, Ziao Wang, Yanmei Dai, Huijie Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-11-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2021.761548/full |
Similar Items
-
Comparison of CalliSpheres® microspheres drug-eluting beads and conventional transarterial chemoembolization in hepatocellular carcinoma patients: a randomized controlled trial
by: Shi Zhongxing, et al.
Published: (2023-02-01) -
Transarterial chemoembolization with insertion of radioactive seeds for hepatocellular carcinoma
by: You-Bin Wang, et al.
Published: (2023-09-01) -
Transarterial Chemoembolization in Hepatocellular Carcinoma, Albanian Experience.
by: Ilirian Laçi, et al.
Published: (2022-07-01) -
Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
by: Baur J, et al.
Published: (2016-06-01) -
A Rare Complication Following Transarterial Chemoembolization for Hepatocellular Carcinoma
by: Wei-Chen Lin, et al.
Published: (2015-12-01)